February 1, 2024
Gillette Pioneers New Spinal Muscular Atrophy (SMA) Treatments
The neurology team at Gillette Children's continues to be one of the leading pediatric facilities involved in SMA drug trials and neuromuscular disease research. Xavier and Rose Menke are part of a new generation of children diagnosed with spinal muscular atrophy (SMA) who have a brighter future thanks to new treatment breakthroughs pioneered, in part, by Gillette pediatric neurologist and neuromuscular neurologist, Randal Richardson, MD, and his team.